Pass-Through Status Will Continue Under the New Code Through June 30, 2023 MENLO PARK, Calif. --(BUSINESS WIRE)--Mar. 8, 2021-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that the
MENLO PARK, Calif. --(BUSINESS WIRE)--Feb. 23, 2021-- Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that it will release fourth quarter and full year 2020 financial results on Tuesday,
MENLO PARK, Calif. --(BUSINESS WIRE)--Feb. 11, 2021-- Intersect ENT ® , Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced the U.S. availability of the new Straight Delivery System (“SDS”) packaged with the
MENLO PARK, Calif. --(BUSINESS WIRE)--Feb. 1, 2021-- Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Tom West , President & Chief Executive Officer, and Randy Meier , Executive Vice
Approval Establishes New S Code for PROPEL to Facilitate Specific Coding & Payment MENLO PARK, Calif. --(BUSINESS WIRE)--Jan. 19, 2021-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that
- Preliminary Unaudited Fourth Quarter 2020 Revenue Expected to be $27.7 to $28.1 Million - MENLO PARK, Calif. --(BUSINESS WIRE)--Jan. 12, 2021-- Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today
MENLO PARK, Calif. --(BUSINESS WIRE)--Dec. 17, 2020-- Presentation time in the release dated December 17, 2020 , should read 2 p.m. ET (instead of 5 p.m. ET ). The updated release reads: INTERSECT ENT TO PRESENT AT THE 39 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Intersect ENT, Inc.
Patrick Broderick to Serve as Executive Vice President, General Counsel and Corporate Secretary, and Reyna Fernandez Named as Chief Human Resource Officer MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 17, 2020-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear,
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 5, 2020-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced that management will participate in the following upcoming investor conferences: Berenberg US CEO
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 2, 2020-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today reported financial results for the third quarter ended September 30, 2020 .
